Why is Congress preparing to offer the FDA $28 million, with no explanation for how it addresses the formula crisis?

At best, defenders of the bill justify it as a way to hire needed staff and expedite resolution. At worst, its a reward for incompetence.

As the United States reels in the face of a severe infant formula shortage, Wednesday’s vote from the House of Representatives approved bill H.R.7790, formally referred to as the Infant Formula Supplemental Appropriations Act. Within the text of this single page and simple bill is a straightforward line that reads as follows:

“For an additional amount f…